Endo International Plc Loss Submission Form

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Endo International Plc (NASDAQ: ENDP) who purchased shares between August 8, 2017 and June 10, 2020. The action, which was filed in the United States District Court for the District of New Jersey, alleges that the Company violated federal securities laws.

In particular, the Endo lawsuit alleges that (i) Endo’s and/or its subsidiaries’ contributions to the opioid crisis (including, but not limited to, their opioid products’ disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders have until August 18, 2020 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.

To learn more and keep informed, complete this form >